Patrick J. Nolan

Array ( [id] => 4234508 [patent_doc_number] => 06165799 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Detection of anti-Fc.sub..epsilon. R autoantibodies in asthmatics' [patent_app_type] => 1 [patent_app_number] => 8/985863 [patent_app_country] => US [patent_app_date] => 1997-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3039 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165799.pdf [firstpage_image] =>[orig_patent_app_number] => 985863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129471 [patent_doc_number] => 06033915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Materials and method for the detection and treatment of Wegener\'s granulomatosis' [patent_app_type] => 1 [patent_app_number] => 8/953327 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2076 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033915.pdf [firstpage_image] =>[orig_patent_app_number] => 953327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1373710 [patent_doc_number] => 06555113 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-29 [patent_title] => 'Modulation of cholesteryl ester transfer protein (CETP) activity' [patent_app_type] => B1 [patent_app_number] => 08/945289 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 17861 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555113.pdf [firstpage_image] =>[orig_patent_app_number] => 08945289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560261 [patent_doc_number] => 06361773 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins' [patent_app_type] => B1 [patent_app_number] => 08/943353 [patent_app_country] => US [patent_app_date] => 1997-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 31 [patent_no_of_words] => 20329 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/361/06361773.pdf [firstpage_image] =>[orig_patent_app_number] => 08943353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4362655 [patent_doc_number] => 06255462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Peptide tag for immunodetection and immunopurification' [patent_app_type] => 1 [patent_app_number] => 8/939323 [patent_app_country] => US [patent_app_date] => 1997-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11240 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255462.pdf [firstpage_image] =>[orig_patent_app_number] => 939323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301050 [patent_doc_number] => 06187534 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Methods of evaluating transplant rejection' [patent_app_type] => 1 [patent_app_number] => 8/937063 [patent_app_country] => US [patent_app_date] => 1997-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 7684 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187534.pdf [firstpage_image] =>[orig_patent_app_number] => 937063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493338 [patent_doc_number] => 06342220 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Agonist antibodies' [patent_app_type] => B1 [patent_app_number] => 08/918148 [patent_app_country] => US [patent_app_date] => 1997-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 36563 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342220.pdf [firstpage_image] =>[orig_patent_app_number] => 08918148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288393 [patent_doc_number] => 06197302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Method of stimulating T cells' [patent_app_type] => 1 [patent_app_number] => 8/914421 [patent_app_country] => US [patent_app_date] => 1997-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4284 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197302.pdf [firstpage_image] =>[orig_patent_app_number] => 914421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882477 [patent_doc_number] => 20010048949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'ISOLATED BLADDER SUBMUCOSA FOR TISSUE RECONSTRUCTION' [patent_app_type] => new [patent_app_number] => 08/911218 [patent_app_country] => US [patent_app_date] => 1997-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2788 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20010048949.pdf [firstpage_image] =>[orig_patent_app_number] => 08911218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3928572 [patent_doc_number] => 05952483 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Human I.kappa.B-.beta.' [patent_app_type] => 1 [patent_app_number] => 8/903851 [patent_app_country] => US [patent_app_date] => 1997-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9305 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952483.pdf [firstpage_image] =>[orig_patent_app_number] => 903851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342363 [patent_doc_number] => 06590088 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'CD33-like protein' [patent_app_type] => B1 [patent_app_number] => 08/896537 [patent_app_country] => US [patent_app_date] => 1997-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24789 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/590/06590088.pdf [firstpage_image] =>[orig_patent_app_number] => 08896537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3905444 [patent_doc_number] => 06001353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => '20.alpha.-alpha-hydroxy steroid dehydrogenase related material and methods' [patent_app_type] => 1 [patent_app_number] => 8/853839 [patent_app_country] => US [patent_app_date] => 1997-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9991 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001353.pdf [firstpage_image] =>[orig_patent_app_number] => 853839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924477 [patent_doc_number] => 05952226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Hypoxia responsive EPO producing cells' [patent_app_type] => 1 [patent_app_number] => 8/853236 [patent_app_country] => US [patent_app_date] => 1997-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8577 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952226.pdf [firstpage_image] =>[orig_patent_app_number] => 853236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804516 [patent_doc_number] => 05853996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Detection of chronic fatigue syndrome by increased apoptosis and cell cycle arrest of peripheral blood mononuclear cells' [patent_app_type] => 1 [patent_app_number] => 8/843951 [patent_app_country] => US [patent_app_date] => 1997-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 5692 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/853/05853996.pdf [firstpage_image] =>[orig_patent_app_number] => 843951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493358 [patent_doc_number] => 06342227 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Use of IGF-I or analogues thereof in the prevention of diabetes' [patent_app_type] => B1 [patent_app_number] => 08/750733 [patent_app_country] => US [patent_app_date] => 1997-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 4514 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342227.pdf [firstpage_image] =>[orig_patent_app_number] => 08750733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440858 [patent_doc_number] => 06335174 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Oncofetal antigen specific t-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10' [patent_app_type] => B1 [patent_app_number] => 08/835069 [patent_app_country] => US [patent_app_date] => 1997-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 15201 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335174.pdf [firstpage_image] =>[orig_patent_app_number] => 08835069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4152050 [patent_doc_number] => 06107073 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Kinase capable of site-specific phosphorylation of I.kappa.B.alpha.' [patent_app_type] => 1 [patent_app_number] => 8/825559 [patent_app_country] => US [patent_app_date] => 1997-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 51 [patent_no_of_words] => 39039 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107073.pdf [firstpage_image] =>[orig_patent_app_number] => 825559 [rel_patent_id] =>[rel_patent_doc_number] =>)